MONTAGNANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.355
EU - Europa 3.069
AS - Asia 1.467
AF - Africa 181
SA - Sud America 22
OC - Oceania 6
Totale 9.100
Nazione #
US - Stati Uniti d'America 4.333
GB - Regno Unito 856
IT - Italia 528
CN - Cina 506
SE - Svezia 451
VN - Vietnam 391
DE - Germania 386
SG - Singapore 307
UA - Ucraina 199
IN - India 181
IE - Irlanda 167
FR - Francia 124
RU - Federazione Russa 118
EE - Estonia 67
ZA - Sudafrica 58
TG - Togo 54
CH - Svizzera 51
BG - Bulgaria 41
NG - Nigeria 29
JO - Giordania 25
CI - Costa d'Avorio 20
FI - Finlandia 17
SC - Seychelles 16
CA - Canada 13
BE - Belgio 12
IR - Iran 12
NL - Olanda 11
JP - Giappone 10
TR - Turchia 10
PL - Polonia 9
BR - Brasile 8
AT - Austria 5
DK - Danimarca 5
EC - Ecuador 5
MX - Messico 5
CZ - Repubblica Ceca 4
AR - Argentina 3
AU - Australia 3
EG - Egitto 3
GR - Grecia 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RO - Romania 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BO - Bolivia 2
ES - Italia 2
HN - Honduras 2
ID - Indonesia 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
BZ - Belize 1
CL - Cile 1
GL - Groenlandia 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 9.100
Città #
Southend 782
Fairfield 634
Chandler 538
Ashburn 319
Singapore 266
Houston 227
Dong Ket 219
Princeton 207
Seattle 198
Wilmington 194
Woodbridge 185
Dublin 167
Cambridge 164
Ann Arbor 141
Jacksonville 127
Bologna 116
Nanjing 80
Westminster 74
Santa Clara 69
New York 64
Padova 62
Berlin 60
Lomé 54
Saint Petersburg 49
Medford 48
Bern 42
Sofia 40
Boardman 37
Jinan 36
Milan 32
Shenyang 31
Dearborn 30
Abeokuta 29
Hebei 27
San Diego 27
Amman 25
Beijing 25
Bremen 24
Nanchang 24
Florence 23
Redmond 21
Abidjan 20
Changsha 20
Pune 20
Mülheim 18
Guangzhou 16
Helsinki 16
Jiaxing 16
Shanghai 16
Turin 16
Des Moines 15
Los Angeles 15
Mahé 15
Zhengzhou 14
Mountain View 13
Redwood City 13
Taizhou 13
Falls Church 12
Norwalk 12
Tianjin 12
Brussels 11
Hangzhou 11
Olalla 10
Torino 10
Kunming 9
Shenzhen 9
Lanzhou 8
London 8
Paris 8
Rome 8
San Francisco 8
Tokyo 8
Monmouth Junction 7
Ningbo 7
Phoenix 7
Toronto 7
Chengdu 6
Leawood 6
Mumbai 6
Wenzhou 6
Xi'an 6
Andover 5
Bari 5
Fuzhou 5
Granarolo 5
Haikou 5
Hyderabad 5
Leuchtenberg 5
Naples 5
São Paulo 5
Taiyuan 5
Verona 5
Bühl 4
Castelnuovo Rangone 4
Frankfurt am Main 4
Groningen 4
Gualtieri 4
Hanover 4
Nueva Loja 4
Qingdao 4
Totale 6.062
Nome #
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 243
Attitudes of Crohn's Disease Patients: Infodemiology Case Study and Sentiment Analysis of Facebook and Twitter Posts 204
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 188
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 183
Acute Fitz-Hugh-Curtis Syndrome in a Man due to Gonococcal Infection 180
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 178
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 171
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 168
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 167
The future of dual therapy for hepatitis C virus 159
A Patient With Pancreas Divisum, Recurrent Acute Pancreatitis, and Homozygosity for the Cystic Fibrosis Transmembrane Regulator–Associated Protein 5T Allele 159
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 157
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 146
Alisporivir for the treatment of chronic HCV 139
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 138
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 138
Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. 133
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 132
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. 128
Understanding Crohn's disease patients reaction to infliximab from facebook: A medical perspective 127
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 127
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 122
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 121
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption 121
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi 120
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 120
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 118
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 111
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 108
PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE 106
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 106
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 104
Pharmacological modulation of MRP2 in primary biliary cirrhosis 103
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 103
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 101
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 97
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 95
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy 95
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 95
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on 93
Semisynthetic bile acid FXR and TGR5 agonists: Physicochemical properties, pharmacokinetics, and metabolism in the rats 92
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 92
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 92
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 91
Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. 90
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 89
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 88
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 88
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 88
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 87
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 87
Malattie colestatiche del fegato. Rapporti tra fegato e gravidanza. In: Cirrosi epatica: epidemiologia, diagnosi e terapia. 87
INFEZIONI E INFESTAZIONI DELL’APPARATO DIGERENTE (capitolo 56) 86
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 83
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 83
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 83
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 82
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 82
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 82
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 80
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 80
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 79
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 78
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 76
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 76
null 75
Infezioni, infestazioni, patologia gastroenterologica emergente dall’immigrazione (capitolo 56) 74
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 72
Treatment of acute hepatitis B with high dose lamivudine 69
Metabolic, nutritional and immunological parameters in healthy volunteers after inulin and saccharose feeding 67
Prevalence of different PPAR-alpha gene polymorphisms and haplotypes in gallstone patients. Dig Liv Dis 2005;Vol. 37 Suppl.1:S36. 67
Effects of cholesterol 7alpha-hydroxylase promoter polymorphisms on basal promoter activity and feedback regulation of bile acid synthesis 66
null 65
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 64
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis 63
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 63
MDR3 mutations in a large cohort of italian women with intrahepatic cholestasis of pregnancy 59
Bile acids: Physico-chemical properties, function and activity 57
Cholic acid metabolism in human fecal cultures during diet supplementation with Lactobacillus rhamnosus GG 55
Alcolismo e patologie alcool-correlate 52
A comparison of the analytical performance of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrospray and matrix-assisted laser desorption/ionization mass spectrometry in the study of the protein extract from bothrops jararaca snake venom 51
Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring 49
Bile acid structure and intestinal absorption in the animal model 48
FISIOPATOLOGIA GASTRICA 48
Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. 43
Gastric autoimmune disorders in patients with chronic hepatitis C before, during the after interferon-alpha therapy 43
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid 40
Hepatic uptake and intestinal absorption of bile acids in the rabbit 38
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial 31
Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial 31
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 30
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 30
Absence of dysfunctional ileal sodium - Bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption 29
Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver 28
Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells 28
GASTRIC PATHOPHYSIOLOGY 27
Intestinal absorption of bile acids in the rabbit: Different transport rates in jejunum and ileum 27
Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells 27
Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification 26
LIVING DRUGS Attualità sui Probiotici 23
Totale 9.190
Categoria #
all - tutte 24.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.610 0 0 0 113 188 213 248 258 274 129 70 117
2020/20211.136 219 71 43 44 21 37 25 63 128 52 46 387
2021/20221.978 157 70 100 109 134 82 39 97 106 124 638 322
2022/20231.991 242 286 124 235 124 161 52 105 337 47 166 112
2023/2024678 34 94 33 119 50 178 30 30 36 26 23 25
2024/2025689 83 350 183 73 0 0 0 0 0 0 0 0
Totale 9.339